147 related articles for article (PubMed ID: 1472493)
1. Potent slow-binding inhibition of cathepsin B by its propeptide.
Fox T; de Miguel E; Mort JS; Storer AC
Biochemistry; 1992 Dec; 31(50):12571-6. PubMed ID: 1472493
[TBL] [Abstract][Full Text] [Related]
2. The occluding loop in cathepsin B defines the pH dependence of inhibition by its propeptide.
Quraishi O; Nägler DK; Fox T; Sivaraman J; Cygler M; Mort JS; Storer AC
Biochemistry; 1999 Apr; 38(16):5017-23. PubMed ID: 10213604
[TBL] [Abstract][Full Text] [Related]
3. Potency and selectivity of inhibition of cathepsin K, L and S by their respective propeptides.
Guay J; Falgueyret JP; Ducret A; Percival MD; Mancini JA
Eur J Biochem; 2000 Oct; 267(20):6311-8. PubMed ID: 11012686
[TBL] [Abstract][Full Text] [Related]
4. Inhibition of cathepsin B by its propeptide: use of overlapping peptides to identify a critical segment.
Chagas JR; Ferrer-Di Martino M; Gauthier F; Lalmanach G
FEBS Lett; 1996 Sep; 392(3):233-6. PubMed ID: 8774851
[TBL] [Abstract][Full Text] [Related]
5. Potency and selectivity of the cathepsin L propeptide as an inhibitor of cysteine proteases.
Carmona E; Dufour E; Plouffe C; Takebe S; Mason P; Mort JS; Ménard R
Biochemistry; 1996 Jun; 35(25):8149-57. PubMed ID: 8679567
[TBL] [Abstract][Full Text] [Related]
6. The slow-binding inhibition of cathepsin K by its propeptide.
Billington CJ; Mason P; Magny MC; Mort JS
Biochem Biophys Res Commun; 2000 Oct; 276(3):924-9. PubMed ID: 11027570
[TBL] [Abstract][Full Text] [Related]
7. The inhibition of cathepsin S by its propeptide--specificity and mechanism of action.
Maubach G; Schilling K; Rommerskirch W; Wenz I; Schultz JE; Weber E; Wiederanders B
Eur J Biochem; 1997 Dec; 250(3):745-50. PubMed ID: 9461297
[TBL] [Abstract][Full Text] [Related]
8. Expression and alteration of the S2 subsite of the Leishmania major cathepsin B-like cysteine protease.
Chan VJ; Selzer PM; McKerrow JH; Sakanari JA
Biochem J; 1999 May; 340 ( Pt 1)(Pt 1):113-7. PubMed ID: 10229665
[TBL] [Abstract][Full Text] [Related]
9. Structure of rat procathepsin B: model for inhibition of cysteine protease activity by the proregion.
Cygler M; Sivaraman J; Grochulski P; Coulombe R; Storer AC; Mort JS
Structure; 1996 Apr; 4(4):405-16. PubMed ID: 8740363
[TBL] [Abstract][Full Text] [Related]
10. Inhibition of cysteine proteinases and dipeptidyl peptidase I by egg-white cystatin.
Nicklin MJ; Barrett AJ
Biochem J; 1984 Oct; 223(1):245-53. PubMed ID: 6388564
[TBL] [Abstract][Full Text] [Related]
11. Chemical evidence for the pH-dependent control of ion-pair geometry in cathepsin B. Benzofuroxan as a reactivity probe sensitive to differences in the mutual disposition of the thiolate and imidazolium components of cysteine proteinase catalytic sites.
Willenbrock F; Brocklehurst K
Biochem J; 1986 Aug; 238(1):103-7. PubMed ID: 3800926
[TBL] [Abstract][Full Text] [Related]
12. Crystal structure of human procathepsin X: a cysteine protease with the proregion covalently linked to the active site cysteine.
Sivaraman J; Nägler DK; Zhang R; Ménard R; Cygler M
J Mol Biol; 2000 Jan; 295(4):939-51. PubMed ID: 10656802
[TBL] [Abstract][Full Text] [Related]
13. Inhibition of cathepsin B and papain by peptidyl alpha-keto esters, alpha-keto amides, alpha-diketones, and alpha-keto acids.
Hu LY; Abeles RH
Arch Biochem Biophys; 1990 Sep; 281(2):271-4. PubMed ID: 2393300
[TBL] [Abstract][Full Text] [Related]
14. Fluorogenic peptide substrates for carboxydipeptidase activity of cathepsin B.
Stachowiak K; Tokmina M; Karpińska A; Sosnowska R; Wiczk W
Acta Biochim Pol; 2004; 51(1):81-92. PubMed ID: 15094828
[TBL] [Abstract][Full Text] [Related]
15. Delineating functionally important regions and residues in the cathepsin B propeptide for inhibitory activity.
Chen Y; Plouffe C; Ménard R; Storer AC
FEBS Lett; 1996 Sep; 393(1):24-6. PubMed ID: 8804416
[TBL] [Abstract][Full Text] [Related]
16. Noncovalent complexes between the lysosomal proteinase cathepsin B and its propeptide account for stable, extracellular, high molecular mass forms of the enzyme.
Mach L; Mort JS; Glössl J
J Biol Chem; 1994 Apr; 269(17):13036-40. PubMed ID: 8175724
[TBL] [Abstract][Full Text] [Related]
17. Regulation of the Fasciola hepatica newly excysted juvenile cathepsin L3 (FhCL3) by its propeptide: a proposed 'clamp-like' mechanism of binding and inhibition.
Pritsch IC; Tikhonova IG; Jewhurst HL; Drysdale O; Cwiklinski K; Molento MB; Dalton JP; Verissimo CM
BMC Mol Cell Biol; 2020 Dec; 21(1):90. PubMed ID: 33287692
[TBL] [Abstract][Full Text] [Related]
18. Molecular mechanism of inhibition of cysteine proteinases by their protein inhibitors: kinetic studies with natural and recombinant variants of cystatins and stefins.
Machleidt W; Thiele U; Assfalg-Machleidt I; Förger D; Auerswald EA
Biomed Biochim Acta; 1991; 50(4-6):613-20. PubMed ID: 1801731
[TBL] [Abstract][Full Text] [Related]
19. Purification and characterization of a low molecular weight cysteine proteinase inhibitor from bovine muscle.
Bige L; Ouali A; Valin C
Biochim Biophys Acta; 1985 Dec; 843(3):269-75. PubMed ID: 3877527
[TBL] [Abstract][Full Text] [Related]
20. Importance of the evolutionarily conserved glycine residue in the N-terminal region of human cystatin C (Gly-11) for cysteine endopeptidase inhibition.
Hall A; Dalbøge H; Grubb A; Abrahamson M
Biochem J; 1993 Apr; 291 ( Pt 1)(Pt 1):123-9. PubMed ID: 8471031
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
